Herbal medicines long have been used in the management of diabetes mellitus (DM).
This study was conducted to ascertain if fenugreek compared with glibenclamide had any impacts on controlling
blood glucose in patients with uncontrolled type II DM on conventional therapy.
A total of 12 patients with uncontrolled DM and on metformin were recruited and divided into two groups. Patients
in group 1 received 2 g fenugreek per day, whereas those in group 2 received glibenclamide 5 mg once daily. The impacts of
fenugreek on the glycemic control and lipid profile were measured before initiation of the regimen and then after 12 weeks.
Only 9 of the 12 study participants completed the study. Fenugreek at 2 g/day caused an insignificant drop in fasting
blood glucose (P = 0.63), but the fasting insulin level increased significantly (P = 0.04). The ratio of high- to low-density lipoprotein was significantly decreased from before to after treatment (P = 0.006). Fenugreek did not cause any notable adverse impacts
on hepatic and renal functions throughout the study.
Fenugreek could be used as adjuvant therapy to anti-diabetic drugs to control blood glucose, and further studies
Cite as: Najdi RA, Hagras MM, Kamel FO, RM M. A randomized controlled clinical trial evaluating the effect of Trigonella foenum-graecum
(fenugreek) versus glibenclamide in patients with diabetes. Afri Health Sci. 2019;19(1). 1594-1601. https://dx.doi.org/10.4314/ahs.v19i1.34